CINC
Income statement / Annual
Last year (2021), CinCor Pharma, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2021, CinCor Pharma, Inc.'s net income was -$50.35 M.
See CinCor Pharma, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
| Research and Development Expenses |
$21.51 M
|
$17.95 M
|
$3.93 M
|
| General & Administrative Expenses |
$21.00 M
|
$3.17 M
|
$1.21 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$21.00 M
|
$3.17 M
|
$1.21 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$42.51 M
|
$21.13 M
|
$5.14 M
|
| Cost And Expenses |
$42.51 M
|
$21.13 M
|
$5.14 M
|
| Interest Income |
$21,641.00
|
$36,728.00
|
$101,706.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$7.88 M
|
$1.21 M
|
$171,860.00
|
| EBITDA |
-$34.63 M |
-$19.92 M |
-$5.14 M |
| EBITDA Ratio |
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$7.86 M
|
-$1.17 M
|
$101,706.00
|
| Income Before Tax |
-$50.37 M
|
-$22.30 M
|
-$5.04 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
| Income Tax Expense |
-$21,641.00
|
-$36,728.00
|
-$101,706.00
|
| Net Income |
-$50.35 M
|
-$22.26 M
|
-$4.93 M
|
| Net Income Ratio |
0
|
0
|
0
|
| EPS |
-1.42 |
-0.95 |
-0.21 |
| EPS Diluted |
-1.42 |
-0.95 |
-0.21 |
| Weighted Average Shares Out |
$35.42 M
|
$23.49 M
|
$23.49 M
|
| Weighted Average Shares Out Diluted |
$35.42 M
|
$23.49 M
|
$23.49 M
|
| Link |
|
|
|
